Title : Idebenone-Activating Autophagic Degradation of α-Synuclein via Inhibition of AKT-mTOR Pathway in a SH-SY5Y-A53T Model of Parkinson's Disease: A Network Pharmacological Approach.

Pub. Date : 2021

PMID : 34567221






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Idebenone-Activating Autophagic Degradation of alpha-Synuclein via Inhibition of AKT-mTOR Pathway in a SH-SY5Y-A53T Model of Parkinson"s Disease: A Network Pharmacological Approach. idebenone AKT serine/threonine kinase 1 Homo sapiens
2 The enrichment analysis highlighted manipulation of MAP kinase activity and the PI3K-AKT signaling pathway as potential pharmacological targets for Idebenone against PD. idebenone AKT serine/threonine kinase 1 Homo sapiens
3 Additionally, molecular docking showed that AKT and MAPK could bind tightly with Idebenone. idebenone AKT serine/threonine kinase 1 Homo sapiens
4 In the cell model of PD, Idebenone activated autophagy and promoted alpha-synuclein degradation by suppressing the AKT/mTOR pathway. idebenone AKT serine/threonine kinase 1 Homo sapiens